Skip Navigation


Carcinogenesis Advance Access originally published online on June 29, 2005
Carcinogenesis 2006 27(1):112-116; doi:10.1093/carcin/bgi172
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
27/1/112    most recent
bgi172v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (18)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Marsit, C. J.
Right arrow Articles by Kelsey, K. T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Marsit, C. J.
Right arrow Articles by Kelsey, K. T.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Carcinogenesis vol.27 no.1 © Oxford University Press 2005; all rights reserved.

Carcinogen exposure and gene promoter hypermethylation in bladder cancer

Carmen J. Marsit 1, Margaret R. Karagas 3, Hadi Danaee 1, Mei Liu 1, Angeline Andrew 3, Alan Schned 4, Heather H. Nelson 4 and Karl T. Kelsey 1, 2, *

1 Department of Genetics and Complex Diseases and 2 Department of Environmental Health, Harvard School of Public Health, Boston, MA 02115, USA, 3 Department of Community and Family Medicine and 4 Department of Pathology, Dartmouth Medical School, Lebanon, NH 03756, USA

* To whom correspondence should be addressed. Tel: +1 617 432 3313; Fax: +1 617 432 0107; Email: kelsey{at}hsph.harvard.edu

Tobacco smoking, certain occupational exposures, and exposure to inorganic arsenic in drinking water have been associated with the occurrence of bladder cancer. However, in these tumors the exposure-associated pattern of somatic alterations in genes in the causal pathway for disease has been poorly characterized. In particular, the mechanism by which arsenic induces bladder cancer and the effects of lower environmental levels of exposure remain uncertain. Animal and in-vitro studies have suggested that arsenic and other exposures may act through epigenetic mechanisms. We, therefore, examined, in a population-based study of human bladder cancer, the relationship between epigenetic silencing of three tumor suppressor genes, p16INK4A, RASSF1A and PRSS3, and exposure to both tobacco and arsenic in bladder cancer. Promoter methylation of each of these genes occurred in ~30% of bladder cancers, and both RASSF1A and PRSS3 promoter methylation were associated with advanced tumor stage (P < 0.001 and P < 0.04, respectively). Arsenic exposure, measured as toenail arsenic, was associated with RASSF1A (P < 0.02) and PRSS3 (P < 0.1) but not p16INK4A promoter methylation, in models adjusted for stage and other factors. Cigarette smoking was associated with a >2-fold increased risk of promoter methylation of the p16INK4A gene only, with greater risk seen in patients with exposures more recent to disease diagnosis. These results, from human bladder tumors, add to the body of animal and in vitro evidence that suggests a role in epigenetic alterations for bladder carcinogens.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 CarcinogenesisHome page
X. Zhou, H. Sun, T. P. Ellen, H. Chen, and M. Costa
Arsenite alters global histone H3 methylation
Carcinogenesis, September 1, 2008; 29(9): 1831 - 1836.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
E. M. Wolff, G. Liang, C. C. Cortez, Y. C. Tsai, J. E. Castelao, V. K. Cortessis, D. D. Tsao-Wei, S. Groshen, and P. A. Jones
RUNX3 Methylation Reveals that Bladder Tumors Are Older in Patients with a History of Smoking
Cancer Res., August 1, 2008; 68(15): 6208 - 6214.
[Abstract] [Full Text] [PDF]

Home page
 CarcinogenesisHome page
T. J. Jensen, P. Novak, K. E. Eblin, A. J. Gandolfi, and B. W. Futscher
Epigenetic remodeling during arsenical-induced malignant transformation
Carcinogenesis, August 1, 2008; 29(8): 1500 - 1508.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
W. Knecht, G. S. Cottrell, S. Amadesi, J. Mohlin, A. Skaregarde, K. Gedda, A. Peterson, K. Chapman, M. D. Hollenberg, N. Vergnolle, et al.
Trypsin IV or Mesotrypsin and p23 Cleave Protease-activated Receptors 1 and 2 to Induce Inflammation and Hyperalgesia
J. Biol. Chem., September 7, 2007; 282(36): 26089 - 26100.
[Abstract] [Full Text] [PDF]

Home page
 CarcinogenesisHome page
C. J. Marsit, E. A. Houseman, A. R. Schned, M. R. Karagas, and K. T. Kelsey
Promoter hypermethylation is associated with current smoking, age, gender and survival in bladder cancer
Carcinogenesis, August 1, 2007; 28(8): 1745 - 1751.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
C. J. Marsit, E. A. Houseman, B. C. Christensen, K. Eddy, R. Bueno, D. J. Sugarbaker, H. H. Nelson, M. R. Karagas, and K. T. Kelsey
Examination of a CpG Island Methylator Phenotype and Implications of Methylation Profiles in Solid Tumors
Cancer Res., November 1, 2006; 66(21): 10621 - 10629.
[Abstract] [Full Text] [PDF]

Home page
 Am J EpidemiolHome page
C. M. Ross
RE: "CIGARETTE SMOKING AND INCIDENCE OF FIRST DEPRESSIVE EPISODE: AN 11-YEAR, POPULATION-BASED FOLLOW-UP STUDY"
Am. J. Epidemiol., November 1, 2006; 164(9): 917 - 918.
[Full Text] [PDF]


Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.